SCHEMBL17414697

SCHEMBL17414697

Cc1cccc2c1-c1c(C)cccc1OCCCO2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K14 Q99558 2/20 0.47
ITGB2 P05107 1/20 0.42
ICAM1 P05362 1/20 0.42
ITGAL P20701 1/20 0.42
PTGER3 P43115 2/20 0.40
ACHE P22303 1/20 0.38
LMNA P02545 2/20 0.38
CRHBP P24387 2/20 0.38
CRHR2 Q13324 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HTT P42858 1/20 0.38
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
CTNNB1 P35222 1/20 0.35
WNT3A P56704 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13255085 0.82 ABCG2 (0.52) MAP3K14PTGER3SMN1; SMN2NPC1RAB9A
SCHEMBL19928557 0.81 DRD1 (0.36) MAP3K14ITGB2ICAM1ITGALPTGER3
SCHEMBL436487 0.81 MAP3K14 (0.46) MAP3K14ITGB2ICAM1ITGALLMNA
SCHEMBL9913796 0.78 DRD1 (0.36) MAP3K14ITGB2ICAM1ITGALPTGER3
SCHEMBL436160 0.77 MAP3K14 (0.46) MAP3K14ITGB2ICAM1ITGALACHE
SCHEMBL769591 0.76 MAP3K14 (0.42) MAP3K14ITGB2ICAM1ITGALPTGER3
SCHEMBL13516866 0.74 ITGB2 (0.42) MAP3K14ITGB2ICAM1ITGALLMNA
SCHEMBL27915696 0.74 HTR7 (0.53) SMN1; SMN2RAB9ACTNNB1WNT3AMAPT
SCHEMBL13191525 0.74 MAP3K14 (0.40) MAP3K14ITGB2ICAM1ITGALACHE
SCHEMBL9351 0.73 ITGB2 (0.77) ITGB2ICAM1ITGALLMNACRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828340-B2 Asymmetric synthesis of a substituted pyrrolidine-2-carboxamide HOFFMANN-LA ROCHE INC. (US) 2017-11-28 US disclosed
EP-2958893-B1 ASYMMETRIC SYNTHESIS OF A SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDE HOFFMANN LA ROCHE (CH) 2017-05-03 EP disclosed
US-20160002158-A1 ASYMMETRIC SYNTHESIS OF A SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDE HOFFMANN-LA ROCHE AG (US) 2016-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160002158-A1 ASYMMETRIC SYNTHESIS OF A SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDE ALDH18A1, PAH, DDC MAP3K14 3260/4885ITGB2 4586/4885ICAM1 4813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.